EPCAM and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Although the EpCAM BiTE was tested on pancreatic cancer cells and CSCs at a preclinical level with encouraging results, Phase I clinical studies did not include PaCa patients.